Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026)

Cresco Labs (CRLBF) posted Cash & Current Investments of $63.6 million for Q1 2026, down 30.21% on a QoQ basis from $91.1 million in Q4 2025, and up 1709.65% year-over-year from $3.5 million in Q1 2025.

Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026) Analysis & Trends

Cresco Labs' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $63.6 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 1709.65% year-over-year to $63.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.6 million (up 431.64% YoY) and the FY2025 annual result came in at $91.1 million, up 2548.62% from the prior year.
  • Cash & Current Investments was $63.6 million for Q1 2026 at Cresco Labs, down from $91.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $228.7 million in Q1 2022 and bottomed at $1.7 million in Q1 2024.
  • A 5-year average of $59.7 million and a median of $33.3 million in 2025 frame the typical range for Cash & Current Investments.
  • Peak annual rise in Cash & Current Investments reached 2548.62% in 2025, while the deepest fall reached 97.28% in 2025.
  • Cresco Labs' Cash & Current Investments stood at $228.7 million in 2022, then tumbled by 52.55% to $108.5 million in 2023, then sank by 96.83% to $3.4 million in 2024, then surged by 2548.62% to $91.1 million in 2025, then tumbled by 30.21% to $63.6 million in 2026.
  • Business Quant data shows CRLBF's Cash & Current Investments at $63.6 million in Q1 2026, $91.1 million in Q4 2025, and $33.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Cresco Labs 245.85 Mn 182.28 Mn 75.45 Mn 63.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.57 Mn
Dec 31, 2025 91.09 Mn
Sep 30, 2025 33.29 Mn
Jun 30, 2025 3.15 Mn
Mar 31, 2025 3.51 Mn
Dec 31, 2024 3.44 Mn
Sep 30, 2024 3.26 Mn
Jun 30, 2024 115.95 Mn
Mar 31, 2024 1.75 Mn
Dec 31, 2023 108.52 Mn
Mar 31, 2022 228.70 Mn
Dec 31, 2021 5.12 Mn
Sep 30, 2021 202.41 Mn
Jun 30, 2021 135.23 Mn
Mar 31, 2021 262.44 Mn
Dec 31, 2020 8.87 Mn
Sep 30, 2020 59.62 Mn
Mar 31, 2020 70.03 Mn
Dec 31, 2019 1.15 Bn